Talon Resources Targets Ontario Gold Growth After AIM Move and Eagle Lake Acquisition, CEO Says.Watch here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBiotech Gwth Regulatory News (BIOG)

Share Price Information for Biotech Gwth (BIOG)

Share Price is delayed by 15 minutes
Get Live Data
1,446.00    42.00 (2.99%)
Bid:
1,446.00
Ask:
1,456.00
Spread: 10.00 (0.692%)
Market Cap: £278.46m
BIOG Live PriceLast checked at - London Stock Exchange

Intraday Biotech Gwth Share Chart

Investor Webinar

29 Sep 2025 15:22

The Biotech Growth Trust PLC - Investor Webinar

The Biotech Growth Trust PLC - Investor Webinar

PR Newswire

LONDON, United Kingdom, September 29

For immediate release

29 September 2025

 

THE BIOTECH GROWTH TRUST PLC

(the "Company")

 

Investor Webinar: Tuesday, 7 October, 3pm UK (1 hour duration)

 

The Company is pleased to announce that Geoff Hsu and Josh Golomb, portfolio managers, will be providing an update on the Company, including investment performance and portfolio positioning for the rest of 2025 and into 2026, on Tuesday 7 October 2025 at 3pm UK time.  The presentation is expected to last approximately 30 minutes with time for questions and answers in the second half, with the aim to complete the webinar by 4pm.

The webinar is open to all professional existing and prospective shareholders. Registration is free and a certificate of attendance can be provided if appropriate. The webinar will also be made available on the Frostrow Capital YouTube page.

To register, or for further information, please contact Frostrow Investor Relations: ir@frostrow.com

 

For and on behalf of

Frostrow Capital LLP

Company Secretary

 

 



Date   Source Headline
23rd Jun 202612:46 pmPRNNet Asset Value(s)
22nd Jun 20262:34 pmPRNNet Asset Value(s)
19th Jun 20265:10 pmPRNTransaction in Own Shares
19th Jun 20261:44 pmPRNNet Asset Value(s)
18th Jun 20261:05 pmPRNNet Asset Value(s)
17th Jun 20261:01 pmPRNNet Asset Value(s)
16th Jun 202612:48 pmPRNNet Asset Value(s)
15th Jun 202612:43 pmPRNNet Asset Value(s)
12th Jun 20265:39 pmPRNTransaction in Own Shares
12th Jun 20263:48 pmPRNNet Asset Value(s)
11th Jun 20261:32 pmPRNNet Asset Value(s)
10th Jun 20263:07 pmPRNMonthly Fact Sheet as at 31 May 2026
10th Jun 20261:33 pmPRNNet Asset Value(s)
9th Jun 20261:57 pmPRNGSK plc to acquire BIOG portfolio company, Nuvalent, Inc.
9th Jun 202612:47 pmPRNNet Asset Value(s)
8th Jun 20261:58 pmPRNNet Asset Value(s)
5th Jun 20265:29 pmPRNTransaction in Own Shares
5th Jun 20262:57 pmPRNNet Asset Value(s)
4th Jun 20262:23 pmPRNNet Asset Value(s)
3rd Jun 20263:56 pmPRNNet Asset Value(s)
3rd Jun 20267:00 amPRNAnnual Financial Report
2nd Jun 202612:32 pmPRNNet Asset Value(s)
1st Jun 20263:04 pmPRNNet Asset Value(s)
1st Jun 202611:12 amPRNTotal Voting Rights
29th May 20265:22 pmPRNTransaction in Own Shares
29th May 20261:56 pmPRNNet Asset Value(s)
28th May 202612:52 pmPRNNet Asset Value(s)
27th May 20261:40 pmPRNNet Asset Value(s)
26th May 20261:15 pmPRNNet Asset Value(s)
22nd May 20265:19 pmPRNTransaction in Own Shares
22nd May 20261:30 pmPRNNet Asset Value(s)
21st May 20261:47 pmPRNNet Asset Value(s)
20th May 20261:07 pmPRNNet Asset Value(s)
19th May 20263:56 pmPRNNet Asset Value(s)
18th May 20262:33 pmPRNNet Asset Value(s)
15th May 20265:30 pmPRNTransaction in Own Shares
15th May 20263:00 pmPRNNet Asset Value(s)
14th May 20265:16 pmPRNMonthly Fact Sheet as at 30 April 2026
14th May 20261:02 pmPRNNet Asset Value(s)
13th May 20262:46 pmPRNNet Asset Value(s)
12th May 20261:02 pmPRNNet Asset Value(s)
11th May 20261:33 pmPRNNet Asset Value(s)
8th May 20265:21 pmPRNTransaction in Own Shares
8th May 20261:56 pmPRNNet Asset Value(s)
7th May 202612:58 pmPRNNet Asset Value(s)
6th May 20262:09 pmPRNNet Asset Value(s)
5th May 20261:49 pmPRNNet Asset Value(s)
1st May 20265:32 pmPRNCompliance with Market Abuse Regulation
1st May 20265:20 pmPRNTransaction in Own Shares
1st May 20262:47 pmPRNARCHIMED to acquire BIOG portfolio company, Esperion Therapeutics.

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.